Search clinical trials for: breast cancer 1, early onset (BRCA1)
Total 133311 results
-
Centre Georges Francois LeclercNot yet recruiting
-
Alexandru EniuIuliu Hatieganu University of Medicine and PharmacyCompletedTo Determine the Prevalence, Penetrance of BRCA1 and BRCA2 Mutations in Romanian Womens With Breast or Ovarian CancerRomania
-
Data Collection Analysis Business ManagementPAS Research ServicesUnknownHereditary CancerUnited States
-
Institut Paoli-CalmettesUnknown
-
Fondazione Policlinico Universitario Agostino Gemelli...Completed
-
Fundación Pública Andaluza para la gestión de la...Completed
-
Lund UniversityCompletedHereditary Breast CancerSweden
-
National Cancer Institute (NCI)CompletedBRCA1 Gene | BRCA2 GeneUnited States
-
University of UtahNational Cancer Institute (NCI)CompletedBreast Cancer | Ovarian Cancer | Genetic PredispositionUnited States
-
Chung-Ang UniversityCompletedBRCA Gene RearrangementKorea, Republic of
-
Okayama UniversityMerck Sharp & Dohme LLCRecruitingBreast Cancer | Breast Neoplasms | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | BRCA1 Mutation | BRCA2 Mutation | BRCA Mutation | BRCA-Associated Breast CarcinomaJapan
-
Cancer Trials IrelandActive, not recruitingFallopian Tube Cancer | Primary Peritoneal Carcinoma | Serous Ovarian Tumor | Endometrioid Carcinoma OvaryIreland
-
Mayo ClinicEnrolling by invitation
-
AstraZenecaMerck Sharp & Dohme LLC; NRG Oncology; Breast International Group; Myriad Genetic... and other collaboratorsActive, not recruitingBreast CancerUnited States, Austria, Italy, Spain, Sweden, United Kingdom, Belgium, Poland, France, Switzerland, Canada, Germany, Korea, Republic of, Netherlands, Japan, China, Taiwan, Australia, Argentina, Israel, Hungary, Portugal, Iceland, Puerto...
-
PfizerMedivation, Inc.; Myriad Genetic Laboratories, Inc.TerminatedBreast Neoplasms | BRCA 1 Gene Mutation | BRCA 2 Gene MutationUnited States, Spain, United Kingdom, Germany, France
-
Centre Francois BaclesseCompletedHereditary Breast and Ovarian Cancer SyndromeFrance
-
PfizerMedivation, Inc.CompletedBreast Neoplasms | BRCA 1 Gene Mutation | BRCA 2 Gene MutationKorea, Republic of, United States, Australia, Spain, Belgium, France, Ireland, Taiwan, Poland, Germany, Israel, Brazil, United Kingdom, Italy, Russian Federation, Ukraine
-
Sheba Medical CenterUnknownHereditary Breast and Ovarian Cancer SyndromeIsrael
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetic Laboratories, Inc.Active, not recruitingBreast Cancer Metastatic | BRCA 1 Gene Mutation | BRCA 2 Gene MutationItaly, Spain, United States, Czechia, Romania, France, Korea, Republic of, United Kingdom, Hungary, Japan, Peru, Poland, Russian Federation, Turkey, China, Taiwan, Bulgaria, Switzerland, Mexico
-
Severance HospitalCompletedBreast Cancer | Breast NeoplasmsKorea, Republic of
-
Dana-Farber Cancer InstituteMedical University of South Carolina; National Cancer Institute (NCI); Massachusetts... and other collaboratorsCompletedBreast Cancer | Ovarian CancerUnited States
-
University of MalayaPfizer; Cancer Research Malaysia; Pantai Hospital Kuala Lumpur; Hospital Sultan...RecruitingTriple Negative Breast Cancer | HRD 100 Gene Expression HighMalaysia
-
Memorial Sloan Kettering Cancer CenterUniversity of Pennsylvania; University of California, Los Angeles; Dana-Farber... and other collaboratorsActive, not recruiting
-
University of PennsylvaniaUnited States Department of DefenseCompleted
-
Jiangxi Qingfeng Pharmaceutical Co. Ltd.UnknownBreast Cancer Metastatic | BRCA 1 Gene Mutation | BRCA 2 Gene MutationChina
-
National Cancer Institute (NCI)CompletedAdult Solid Neoplasm | BRCA1 Mutation Carrier | BRCA2 Mutation CarrierUnited States
-
Pamela MunsterNational Cancer Institute (NCI)RecruitingBRCA1 Mutation | BRCA2 Mutation | PALB2 Gene Mutation | ATM Gene Mutation | BRCA Mutation | Checkpoint Kinase 2 Gene MutationUnited States
-
Sheba Medical CenterCompletedHereditary Breast and Ovarian Cancer SyndromeIsrael
-
Memorial Sloan Kettering Cancer CenterMemorial Health University Medical CenterCompleted
-
Heidelberg UniversityCompleted
-
Weill Medical College of Cornell UniversityBasser Research Center for BRCARecruiting
-
University of PennsylvaniaRecruiting
-
Memorial Sloan Kettering Cancer CenterPhenogen SciencesRecruitingGenetic Testing | BRCA1/2United States
-
AstraZenecaCompletedHER2-ve Metastatic Breast Cancer | Germline BRCA1/2 Mutations | Somatic BRCA1/2 MutationsItaly, Spain, Poland, Taiwan, Canada, France, Germany, Korea, Republic of, Hungary, Japan, Russian Federation, Turkey, United Kingdom, United States, Bulgaria
-
Priyanka SharmaBristol-Myers Squibb; Celgene CorporationActive, not recruitingBreast Cancer | Triple-Negative Breast CancerUnited States
-
University of California, San FranciscoAmerican Cancer Society, Inc.CompletedBRCA1 Gene Mutation | BRCA2 Gene MutationUnited States
-
National Cancer Institute (NCI)Recruiting
-
National Human Genome Research Institute (NHGRI)Johns Hopkins Bloomberg School of Public HealthCompleted
-
Abramson Cancer Center at Penn MedicineRecruiting
-
German Breast GroupAstraZenecaCompletedBreast Cancer | Triple Negative Breast Neoplasms | HRpos Breast Neoplasms | BRCA 1 /2 and / or HRDGermany
-
Ohio State University Comprehensive Cancer CenterRecruitingBRCA1 Gene Mutation | BRCA2 Gene MutationUnited States
-
The Netherlands Cancer InstituteTesaro, Inc.TerminatedBreast CancerNetherlands
-
Hadassah Medical OrganizationUnknownBreast Cancer | Ovarian CancerIsrael
-
Azienda Ospedaliera Universitaria Policlinico Paolo...Unknown
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Unknown
-
University of PennsylvaniaInovio PharmaceuticalsRecruiting
-
University Hospital, MontpellierCompleted
-
Spanish Lung Cancer GroupCompletedNon-small-cell Lung CancerSpain
-
Jazz PharmaceuticalsCompletedColorectal NeoplasmsUnited States, Canada
-
University of California, San FranciscoGlaxoSmithKlineRecruitingMetastatic Solid Tumor | BRCA1 Mutation | BRCA2 Mutation | PALB2 Gene Mutation | ATM Gene MutationUnited States